Actemra & Systemic Juvenile Idiopathic Arthritis

New data being presented at the European League Against Rheumatism (EULAR) congress demonstrates that RoActemra (known as Actemra outside Europe) is highly effective in improving the signs and symptoms of systemic juvenile idiopathic arthritis (SJIA), a severe childhood arthritis, where there are no currently licensed treatments.

More Info: http://online.wsj.com/article/BT-CO-20100618-700308.html?mod=WSJ_World_MIDDLEHeadlinesEurope

Actemra

ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA is used to treat adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a tumor necrosis factor (TNF) antagonist has been used and did not work well.

  • It works differently from all other medicines to fight RA, by specifically blocking the action of IL-6.
  • ACTEMRA is given by intravenous (IV) infusion about every four weeks. The infusion takes approximately one hour.

More Info: http://www.actemra.com

I’m just curious, has anyone tried Actemra yet?

3 Comments
3 comments
  1. Jennifer says:

    Morning!
    Yes I am on Actemra here in Australia. I have had about 10 infusions and it is working well :-) I don’t have many side effects just tired after my infusion for a day or 2 and a stuffy nose. I was in pain a few weeks ago but in was my fibro playing up and not my RA so I am lowering my pred again – down to 12.5mg YAY!
    It is meant to be having some amazing results.

  2. Laurie says:

    wish my insurance would get on board with Actemra….it always has to be a battle for new meds.

  3. patricksmom says:

    My son has had JRA since age 11. No doctor put him on any medication until age 14–methotrexate. School was a complete loss that year and half the next. Then the methotrexate was removed and Enbrel was started and it helped for a year or two, but now pain and swelling are back and methotrexate seems to be the only option. I’m going to look into actemra.

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>